Retrospective analysis of antimicrobial susceptibility profiles of non- diphtheriae Corynebacterium species from a tertiary hospital and reference laboratory, 2012–2023
- 11 December 2024
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 62 (12) , e0119924
Abstract
A total of 1,925 Corynebacterium isolates were tested for antimicrobial susceptibility at the Mayo Clinic Microbiology laboratory (Rochester, Minnesota) from January 2012 to March 2023, with C. striatum (35.6%) and C. amycolatum (24.4%) identified as the predominant species. Species known to potentially carry diphtheria toxin were excluded. Common sources of isolation included skin and soft tissue (56.8%), bone and/or native joint synovial fluid (14.2%), urine (13.1%), sputum (6.1%), and blood (5.9%). For penicillin, susceptibility decreased from 47.5% (58 of 122) in 2012 to 20.6% (14 of 68) in 2023. Isolates also showed a decrease in susceptibility to erythromycin from 22.4% (26 of 116) in 2012 to 13.2% (9 of 68) in 2023. Susceptibility to trimethoprim-sulfamethoxazole averaged around 50% throughout the period. Notably, linezolid and vancomycin were universally effective in vitro against all species. The highest susceptibility rates among tested oral agents were to linezolid and doxycycline for non- C . striatum species. Daptomycin minimal inhibitory concentrations (MICs) of >256 µg/mL were observed for one C. amycolatum isolate, one C. tuberculostearicum isolate, and for seven C. striatum isolates, all from patients with prior daptomycin exposure. Daptomycin MICs of 2 µg/mL (nonsusceptible) were observed in one C. striatum isolate recovered from a daptomycin-naïve patient and in six C. jeikeium isolates, from both daptomycin-exposed and non-exposed patients. Significant variation in susceptibility profiles across different Corynebacterium species underscores the importance of performing antimicrobial susceptibility testing to guide effective treatment. Moreover, multidrug resistance observed in C. striatum poses substantial therapeutic challenges especially in patients requiring prolonged or chronic antibiotic suppression.Keywords
Funding Information
- HHS | NIH | National Center for Advancing Translational Sciences (UL1 TR002377)
This publication has 22 references indexed in Scilit:
- Clinical characteristics and drug susceptibility patterns of Corynebacterium species in bacteremic patients with hematological disordersEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- From contamination to infective endocarditis—a population-based retrospective study of Corynebacterium isolated from blood culturesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2019
- Contemporary microbiology and identification ofCorynebacteriaspp. causing infections in humanLetters in Applied Microbiology, 2018
- Emergence of High-Level Daptomycin Resistance in Corynebacterium striatum in Two Patients with Left Ventricular Assist Device InfectionsMicrobial Drug Resistance, 2016
- In Vitro Activity of 22 Antimicrobial Agents against Corynebacterium and Microbacterium Species Referred to the Canadian National Microbiology LaboratoryClinical Microbiology Newsletter, 2015
- Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary taleEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Non-diphtheriae Corynebacterium species: an emerging respiratory pathogenEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Native Valve Endocarditis Caused by Corynebacterium striatum with Heterogeneous High-Level Daptomycin Resistance: Collateral Damage from Daptomycin Therapy?Antimicrobial Agents and Chemotherapy, 2012
- Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient—a review of the literatureEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Urinary Tract Infection due to Corynebacterium urealyticum in Kidney Transplant Recipients: An Underdiagnosed Etiology for Obstructive Uropathy and Graft Dysfunction--Results of a Prospective Cohort StudyClinical Infectious Diseases, 2008